80 related articles for article (PubMed ID: 37242441)
1. A catalog of ethanol-producing microbes in humans.
Mbaye B; Wasfy RM; Alou MT; Borentain P; Gerolami R; Dufour JC; Million M
Future Microbiol; 2024 May; ():. PubMed ID: 38700288
[TBL] [Abstract][Full Text] [Related]
2. Dynamic effects of probiotic formula ecologic®825 on human small intestinal ileostoma microbiota: a network theory approach.
Jansma J; Thome NU; Schwalbe M; Chatziioannou AC; Elsayed SS; van Wezel GP; van den Abbeele P; van Hemert S; El Aidy S
Gut Microbes; 2023; 15(1):2232506. PubMed ID: 37417553
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies.
Maestri M; Santopaolo F; Pompili M; Gasbarrini A; Ponziani FR
Front Nutr; 2023; 10():1110536. PubMed ID: 36875849
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
5. Detection and Quantification of Some Ethanol-Producing Bacterial Strains in the Gut of Mouse Model of Non-Alcoholic Fatty Liver Disease: Role of Metformin.
Abouelkheir M; Taher I; Eladl ASR; Shabaan DA; Soliman MFM; Taha AE
Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242441
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease.
Fei N; Bruneau A; Zhang X; Wang R; Wang J; Rabot S; Gérard P; Zhao L
mBio; 2020 Feb; 11(1):. PubMed ID: 32019793
[TBL] [Abstract][Full Text] [Related]
7. Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae.
Yuan J; Chen C; Cui J; Lu J; Yan C; Wei X; Zhao X; Li N; Li S; Xue G; Cheng W; Li B; Li H; Lin W; Tian C; Zhao J; Han J; An D; Zhang Q; Wei H; Zheng M; Ma X; Li W; Chen X; Zhang Z; Zeng H; Ying S; Wu J; Yang R; Liu D
Cell Metab; 2019 Oct; 30(4):675-688.e7. PubMed ID: 31543403
[TBL] [Abstract][Full Text] [Related]
8. New strain of
Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ
World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795
[TBL] [Abstract][Full Text] [Related]
9. Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae.
Gan L; Feng Y; Du B; Fu H; Tian Z; Xue G; Yan C; Cui X; Zhang R; Cui J; Zhao H; Feng J; Xu Z; Fan Z; Fu T; Du S; Liu S; Zhang Q; Yu Z; Sun Y; Yuan J
Nat Commun; 2023 Jun; 14(1):3215. PubMed ID: 37270557
[TBL] [Abstract][Full Text] [Related]
10. Terminalia bellirica ethanol extract ameliorates nonalcoholic fatty liver disease in mice by amending the intestinal microbiota and faecal metabolites.
Zhang B; Luo X; Han C; Liu J; Zhang L; Qi J; Gu J; Tan R; Gong P
J Ethnopharmacol; 2023 Apr; 305():116082. PubMed ID: 36581163
[TBL] [Abstract][Full Text] [Related]
11. DHA-enriched phosphatidylserine alleviates high fat diet-induced jejunum injury in mice by modulating gut microbiota.
Tian S; Zhao Y; Qian L; Jiang S; Tang Y; Han T
Food Funct; 2023 Feb; 14(3):1415-1429. PubMed ID: 36644847
[TBL] [Abstract][Full Text] [Related]
12. Trimethylamine N-Oxide Levels in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Theofilis P; Vordoni A; Kalaitzidis RG
Metabolites; 2022 Dec; 12(12):. PubMed ID: 36557281
[TBL] [Abstract][Full Text] [Related]
13. Endogenous Ethanol and Triglyceride Production by Gut
Mbaye B; Borentain P; Magdy Wasfy R; Alou MT; Armstrong N; Mottola G; Meddeb L; Ranque S; Gérolami R; Million M; Raoult D
Cells; 2022 Oct; 11(21):. PubMed ID: 36359786
[TBL] [Abstract][Full Text] [Related]
14. Microbiome-derived ethanol in nonalcoholic fatty liver disease.
Meijnikman AS; Davids M; Herrema H; Aydin O; Tremaroli V; Rios-Morales M; Levels H; Bruin S; de Brauw M; Verheij J; Kemper M; Holleboom AG; Tushuizen ME; Schwartz TW; Nielsen J; Brandjes D; Dirinck E; Weyler J; Verrijken A; De Block CEM; Vonghia L; Francque S; Beuers U; Gerdes VEA; Bäckhed F; Groen AK; Nieuwdorp M
Nat Med; 2022 Oct; 28(10):2100-2106. PubMed ID: 36216942
[TBL] [Abstract][Full Text] [Related]
15. Metformin Reverses
Xiao X; Huan Q; Huang Y; Liu Y; Li R; Xu X; Wang Z
Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203765
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
